Table 1.
Demographic and clinical characteristics of the study participant
| TAD (n = 152) | Control subjects (n = 147) | |
|---|---|---|
| Age (mean ± SD) | 51.4 ± 8.9 | 50.2 ± 9.4 |
| Gender distribution (M/F) | 112 (40) | 106 (41) |
| Type A | 43 | |
| Type B | 109 | |
| Smoker, n (%) | 75 (49.3) | 21 (14.2) |
| Hypertension, n (%) | 106 (69.7) | 15 (10.2) |
| Diabetes mellitus, n (%) | 19 (12.5) | 13 (8.8) |
| Acute renal failure, n (%) | 12 (7.8) | – |
| Limb ishemia, n (%) | – | – |
| Serum measurement | ||
| TG (mmol/L) | 2.12 ± 1.43 | 1.82 ± 1.34 |
| TC (mmol/L) | 4.83 ± 1.34 | 4.46 ± 0.98 |
| LDL-C (mmol/L) | 2.85 ± 0.89 | 2.34 ± 0.75 |
| HDL-C (mmol/L) | 1.52 ± 0.36 | 1.43 ± 0.28 |
| Stain, n (%) | 46 (30.3) | 14 (9.5) |
| β-blocker, n (%) | 148 (97.4) | 13 (8.8) |
| ACE-inhibitor, n (%) | 132 (86.8) | 18 (12.3) |
Values for continuous variables are expressed as mean ± S.D. Figures in parentheses are percentages
TAD thoracic aortic dissection, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, TC total cholesterol; TG triglyceride